PROPANC BIOPHARMA, INC. Entity Listing, Par Value Per Share
PROPANC BIOPHARMA, INC. (PPCB) reported Entity Listing, Par Value Per Share of $0.00 per share for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Cover Page
dei:EntityListingParValuePerShare · last filed 2026-05-14
- PROPANC BIOPHARMA, INC. entity listing, par value per share for the quarter ending 2025-09-30 was $0.00, a 0.00% change year-over-year.
- PROPANC BIOPHARMA, INC. entity listing, par value per share for the quarter ending 2024-09-30 was $0.00.
| Period end | Entity Listing, Par Value Per Share 3 month | Entity Listing, Par Value Per Share 6 month | Entity Listing, Par Value Per Share 9 month |
|---|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $0.00 10-Q · filed 2026-02-17 | ||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | ||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | ||
| 2024-12-31 | $0.00 10-Q · filed 2025-02-14 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |